Anton-Scott Goustin - Publications
Affiliations: | Wayne State University, Detroit, MI, United States |
Area:
Insulin signaling in hippocampusYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. Current Cancer Drug Targets. 10: 319-31. PMID 20370686 DOI: 10.2174/156800910791190229 | 0.306 | |||
2008 | Mohammad R, Giri A, Goustin AS. Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer. Recent Patents On Anti-Cancer Drug Discovery. 3: 20-30. PMID 18289121 DOI: 10.2174/157489208783478676 | 0.341 | |||
2007 | Goustin A, Giri A, Wang S, Al-Katib A, Ramzi MM. Surface Plasmon Resonance Study of Apoptotic Regulators Bcl-2, Bcl-w, Bcl-XL, and Mcl-1 Indicate That the Preclinical Small Molecule Inhibitor (SMI) TW-37 Binds to the Hydrophobic Groove Competitively with tBid To Form a Heterodimer Which Cannot Be Disrupted by 200-Fold Molar Excess of TW-37. Blood. 110: 1606-1606. DOI: 10.1182/Blood.V110.11.1606.1606 | 0.307 | |||
Show low-probability matches. |